ahlam1399
08-09-2016, 10:01 PM
Future of drug pricing: paying for benefits **t per pill
LONDON (Reuters) - Global pressure on health spending is forcing the $1 trillion-a-year pharmaceutical industry to look for new ways to price its products: charging based on how much they improve patients' health, rather than how many pills or vials are sold.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=THvoMiyCiQA:BLJvu7SShbc:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=THvoMiyCiQA:BLJvu7SShbc:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=THvoMiyCiQA:BLJvu7SShbc:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=THvoMiyCiQA:BLJvu7SShbc:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=THvoMiyCiQA:BLJvu7SShbc:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/THvoMiyCiQA
LONDON (Reuters) - Global pressure on health spending is forcing the $1 trillion-a-year pharmaceutical industry to look for new ways to price its products: charging based on how much they improve patients' health, rather than how many pills or vials are sold.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=THvoMiyCiQA:BLJvu7SShbc:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=THvoMiyCiQA:BLJvu7SShbc:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=THvoMiyCiQA:BLJvu7SShbc:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=THvoMiyCiQA:BLJvu7SShbc:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=THvoMiyCiQA:BLJvu7SShbc:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/THvoMiyCiQA